Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-08-16
2011-08-16
Jarrell, Noble (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C544S391000
Reexamination Certificate
active
07998964
ABSTRACT:
The present invention is related to N-hydroxyamide derivatives of Formula (I) and use thereof in particular for the treatment and/or prophylaxis of autoimmune disorders, inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, cancer, respiratory diseases and fibrosis, including multiple sclerosis, arthritis, emphysema, chronic obstructive pulmonary disease, liver and pulmonary fibrosis.
REFERENCES:
patent: 6908911 (2005-06-01), Hunter et al.
patent: WO 99/39704 (1999-08-01), None
patent: WO 01/10834 (2001-02-01), None
patent: WO 01/10834 (2001-02-01), None
patent: WO 01/10835 (2001-02-01), None
Clark, et al., Expert Opinion Ther. Targets, 7(1): 19-34 (2003).
Galis, et al., Circ. Res., 90: 251-262 (2002).
Leppert, et al.. Brain Res. Rev., 36: 249-257 (2001).
Makrakis, et al., J. of Maternity Fetal & Neonatal Medicine 14(3): 170-176 (2003).
Skiles, J.W. et al. “The Design, Structure, and Therapeutic Application of Matrix Metalloproteinase Inhibitors”Current Medicinal Chemistry, Mar. 2001, pp. 425-474, vol. 8, No. 4.
Wada, C.K. et al. “Phenoxyphenyl Sulfone N-Formylhydroxylamines (Retrohydroxamates) as Potent, Selective, Orally Bioavailable Matrix Metalloproteinase Inhibitors”Journal of Medicinal Chemistry, 2002, pp. 219-232, vol. 45.
“MMP-12 Inhibitors” Expert Opinion on Therapeutic Patents, 2004, pp. 1637-1640, vol. 14, No. 11, Ashley Publications.
Gonzalez Jerome
Swinnen Dominique
Jarrell Noble
Leeser Erich A
Merck Serono S.A.
Saliwanchik Lloyd & Eisenschenk
LandOfFree
N-hydroxyamide derivatives and use thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with N-hydroxyamide derivatives and use thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-hydroxyamide derivatives and use thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2671580